tiprankstipranks
Trending News
More News >
Axcelis Technologies (ACLS)
NASDAQ:ACLS
Advertisement

Axcelis Technologies (ACLS) AI Stock Analysis

Compare
2,026 Followers

Top Page

ACLS

Axcelis Technologies

(NASDAQ:ACLS)

Rating:78Outperform
Price Target:
$92.00
▲(13.18% Upside)
Axcelis Technologies' strong financial performance and technical momentum are the primary drivers of its high score. The company's robust balance sheet and strategic market leadership in high-energy ion implantation further bolster its position. However, valuation concerns and market softness in certain segments slightly temper the overall outlook.
Positive Factors
Earnings
Axcelis reported a solid beat-and-raise quarter, with both results and guidance exceeding consensus estimates on the top and bottom lines.
Financial Performance
Results for 2Q25 were aided by higher than anticipated gross margins and a lower tax rate, positively impacting earnings.
Market Demand
Continued firm demand in China for SiC applications in the Power segment was noted.
Negative Factors
Market Conditions
The Memory market witnessed a sequential decline in shipments.
Market Exposure
Axcelis has little exposure to AI and advanced nodes that are in control in the semi sector.
Revenue Outlook
Management sees that China revenue will be flat in the second half in dollar terms, implying a significant decline year-over-year.

Axcelis Technologies (ACLS) vs. SPDR S&P 500 ETF (SPY)

Axcelis Technologies Business Overview & Revenue Model

Company DescriptionAxcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. It sells its equipment and services to semiconductor chip manufacturers through its direct sales force. The company was founded in 1978 and is headquartered in Beverly, Massachusetts.
How the Company Makes MoneyAxcelis Technologies generates revenue primarily through the sale of its semiconductor manufacturing equipment, particularly ion implantation systems. The company offers a range of products, including high-energy and low-energy ion implanters, which are essential for various semiconductor fabrication processes. In addition to equipment sales, Axcelis also earns money from aftermarket services, including maintenance, spare parts, and upgrades, which provide a recurring revenue stream. Strategic partnerships with leading semiconductor manufacturers and technology collaborations further enhance its market position and contribute to its earnings. The company's ability to innovate and adapt to the evolving needs of the semiconductor market is a critical factor in its revenue generation.

Axcelis Technologies Earnings Call Summary

Earnings Call Date:Aug 05, 2025
(Q2-2025)
|
% Change Since: 14.69%|
Next Earnings Date:Oct 29, 2025
Earnings Call Sentiment Positive
The earnings call reflected strong financial performance and strategic execution by Axcelis Technologies, with positive outcomes in revenue, profitability, and market leadership, particularly in silicon carbide and high-energy ion implantation. However, challenges remain with a slight decline in bookings, ongoing softness in the memory market, and subdued demand in the general mature segment. Despite these challenges, the company's strong cost management and balance sheet position it well for future opportunities.
Q2-2025 Updates
Positive Updates
Exceeding Financial Expectations
Axcelis Technologies delivered Q2 2025 revenue of $195 million and non-GAAP earnings per diluted share of $1.13, both exceeding the outlook. The company reported strong gross margins and disciplined cost control.
Strong Demand for Silicon Carbide
Continued firm demand for silicon carbide in China, especially driven by the EV industry. The company anticipates a modest improvement in revenue in the second half of 2025 due to this demand.
High Energy Ion Implantation Leadership
Axcelis remains the market and technology leader in high-energy ion implantation, crucial for next-generation architectures like trench and super junction designs.
Efficient Cost Management
The company maintained a strong adjusted EBITDA margin of approximately 20% for the first half of 2025, reflecting disciplined cost management and robust profitability.
Robust Balance Sheet and Share Repurchases
Axcelis exited the quarter with $581 million in cash, cash equivalents, and marketable securities and repurchased approximately $45 million in shares.
Negative Updates
Decline in Bookings
Q2 2025 bookings were $96 million, down slightly on a sequential basis with a book-to-bill ratio of 0.8x. The backlog is $582 million, but bookings reflect ongoing market softness.
Muted Memory Market
The memory equipment market remains muted, with Q2 system revenue declining sequentially. Customers are still digesting existing capacity, and significant capacity additions are not yet occurring.
General Mature Market Softness
Revenue from general mature segments declined slightly on a sequential basis as customers manage capacity investments amid current demand conditions in auto, industrial, and consumer electronics.
Company Guidance
In the second quarter of 2025, Axcelis Technologies reported robust financial performance, surpassing their revenue and non-GAAP earnings per share (EPS) expectations. The company's revenue reached $195 million, with a non-GAAP EPS of $1.13. Axcelis experienced strong gross margins at 45.2%, driven by better-than-expected warranty and installation costs and favorable systems mix. Bookings totaled $96 million, reflecting a book-to-bill ratio of 0.8x. The company's CS&I segment contributed to 30% of total revenue, while China accounted for 65% of system shipments. Despite the cyclically soft demand environment, Axcelis maintained a non-GAAP operating margin of 17.7% and an adjusted EBITDA margin of 20%. The company anticipates modest improvements in revenue for the second half of 2025 and plans to maintain disciplined cost control to manage macroeconomic uncertainties.

Axcelis Technologies Financial Statement Overview

Summary
Axcelis Technologies presents a strong financial position with solid profitability, efficient leverage management, and robust cash flow generation. The recent decline in revenue growth is a concern, but the company continues to maintain healthy margins and a strong balance sheet.
Income Statement
78
Positive
Axcelis Technologies shows strong profitability with a consistent gross profit margin around 44-45% over the years. However, the recent TTM data indicates a decline in revenue growth rate by 6.47%, which is a concern. Despite this, the company maintains a healthy net profit margin of 17.69% in TTM, showcasing efficient cost management. The EBIT and EBITDA margins have slightly decreased in TTM compared to previous years, indicating some pressure on operational efficiency.
Balance Sheet
82
Very Positive
The company maintains a low debt-to-equity ratio, indicating prudent financial leverage management. The return on equity, although slightly decreased in TTM to 15.70%, remains strong, reflecting effective use of shareholder funds. The equity ratio is stable, suggesting a solid financial structure with a good proportion of assets financed by equity.
Cash Flow
75
Positive
Axcelis Technologies demonstrates robust cash flow management with a high free cash flow to net income ratio of 95.66% in TTM. The free cash flow growth rate has rebounded positively in TTM after a decline in the previous year, indicating improved cash generation capabilities. However, the operating cash flow to net income ratio is slightly below 1, suggesting room for improvement in converting income into cash.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue896.09M1.02B1.13B920.00M662.43M474.56M
Gross Profit402.30M454.65M491.30M401.79M286.44M198.58M
EBITDA204.59M251.54M297.01M222.07M136.08M71.04M
Net Income158.49M200.99M246.26M183.08M98.65M49.98M
Balance Sheet
Total Assets1.32B1.35B1.28B1.01B753.24M624.62M
Cash, Cash Equivalents and Short-Term Investments549.84M571.34M506.15M432.17M294.92M203.48M
Total Debt43.00M73.47M75.89M58.71M56.47M52.67M
Total Liabilities301.10M335.99M417.08M346.38M214.28M143.02M
Stockholders Equity1.02B1.01B864.88M667.26M538.96M481.60M
Cash Flow
Free Cash Flow130.07M128.64M136.21M204.92M141.47M62.27M
Operating Cash Flow138.05M140.82M156.87M215.61M150.19M69.70M
Investing Cash Flow-11.58M-108.73M-100.86M-257.25M-8.72M-7.27M
Financing Cash Flow-97.63M-71.19M-68.27M-65.48M-52.45M-2.39M

Axcelis Technologies Technical Analysis

Technical Analysis Sentiment
Positive
Last Price81.29
Price Trends
50DMA
73.74
Positive
100DMA
64.03
Positive
200DMA
66.16
Positive
Market Momentum
MACD
2.32
Positive
RSI
58.86
Neutral
STOCH
24.78
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ACLS, the sentiment is Positive. The current price of 81.29 is above the 20-day moving average (MA) of 77.49, above the 50-day MA of 73.74, and above the 200-day MA of 66.16, indicating a bullish trend. The MACD of 2.32 indicates Positive momentum. The RSI at 58.86 is Neutral, neither overbought nor oversold. The STOCH value of 24.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ACLS.

Axcelis Technologies Risk Analysis

Axcelis Technologies disclosed 25 risk factors in its most recent earnings report. Axcelis Technologies reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Axcelis Technologies Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$2.47B16.6216.19%-19.38%-33.03%
76
Outperform
$1.64B18.5212.32%17.53%27.74%
74
Outperform
$1.26B11.4911.23%-3.19%-11.06%
70
Neutral
$1.44B24.917.83%-0.19%-28.72%
62
Neutral
$2.15B51.824.53%8.30%-63.69%
62
Neutral
$1.90B460.510.66%2.16%-9.54%
61
Neutral
$34.98B7.37-10.82%1.91%8.82%-8.66%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ACLS
Axcelis Technologies
81.29
-28.51
-25.97%
FORM
Formfactor
29.16
-20.47
-41.25%
KLIC
Kulicke & Soffa
37.67
-4.37
-10.39%
PLAB
Photronics
22.08
-1.71
-7.19%
VECO
Veeco
25.25
-11.01
-30.36%
ACMR
ACM Research
30.53
11.93
64.14%

Axcelis Technologies Corporate Events

Executive/Board ChangesShareholder Meetings
Axcelis Technologies Approves Equity Plan Amendment at Annual Meeting
Neutral
May 8, 2025

At the 2025 annual meeting held on May 7, Axcelis Technologies‘ stockholders approved an amendment to the 2012 Equity Incentive Plan, increasing the number of shares reserved for future issuance by 3,000,000. Additionally, the board fixed its size at eight members and appointed Jorge Titinger as the Non-Executive Chairperson. The meeting also ratified the appointment of Ernst & Young LLP as independent auditors and approved the executive compensation for 2024.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2025